Pfizer-BioNTech’s new bivalent Covid-19 vaccine—which targets the original strain and some Omicron subvariants—provides more protection against the virus and its omicron variants than its initial vaccine, according to a study released Friday.
Subscribe to:
Post Comments (Atom)
< + > Human in the Loop Does Not Mean Safe: The Hidden Risks of Agentic AI in Healthcare
The healthcare industry treats artificial intelligence like just another software rollout. We write policies, form committees, and assume st...
No comments:
Post a Comment